Your browser doesn't support javascript.
loading
Protocatechuic acid protects against hepatorenal toxicities in rats exposed to Furan.
Owumi, Solomon E; Bello, Samuel A; Idowu, Temitope B; Arunsi, Uche O; Oyelere, Adegboyega K.
Afiliação
  • Owumi SE; Cancer Research and Molecular Biology Laboratories, Department of Biochemistry, University of Ibadan, Ibadan, Nigeria.
  • Bello SA; Nutrition and Industrial Biochemistry Laboratories, Department of Biochemistry, University of Ibadan, Ibadan, Nigeria.
  • Idowu TB; Nutrition and Industrial Biochemistry Laboratories, Department of Biochemistry, University of Ibadan, Ibadan, Nigeria.
  • Arunsi UO; Department of Cancer Immunology and Biotechnology, School of Medicine, University of Nottingham, Nottingham, UK.
  • Oyelere AK; School of Biochemistry and Chemistry, Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA, USA.
Drug Chem Toxicol ; 45(4): 1840-1850, 2022 Jul.
Article em En | MEDLINE | ID: mdl-33645375
ABSTRACT
Furan formed in processed food is hepatotoxic and likely carcinogenic in humans. We investigated protocatechuic acid (PCA) protective role in rats' hepatorenal function treated with furan. Rats were grouped and treated as follows Control, PCA (50 mg/kg), furan alone (8 mg/kg), furan + PCA1 (25 + 8 mg/kg), and furan + PCA2 (50 + 8 mg/kg). Upon sacrifice, evaluation of hepatorenal function, oxidative stress status, reactive oxygen and nitrogen species (RONS), lipid peroxidation (LPO), myeloperoxidase (MPO) activity, among nitric oxide (NO) levels were performed. Cytokine levels (IL-10, IL-1ß, TNF-alpha), Caspase 3 and 9 activities, and histopathological examination were also assessed. We found that the final body and relative liver weights changed significantly (p < 0.05) in treated groups. Hepatic transaminases, urea, and creatinine increased (p < 0.05) in furan only treated group, and reduced in PCA co-treated groups. The furan-induced decrease in antioxidant status increased RONS, and LPO levels were alleviated (p < 0.05) by PCA co-treatment. Furthermore, furan-mediated increase in NO, IL-1ß, TNF-alpha levels, MPO, Cas-3, and 9 activities and suppressed IL-10 levels was reversed accordingly in rats' kidney and liver co-treated with PCA. The extent of furan-mediated hepatorenal lesions was lessened in PCA co-treated rats. Our findings suggest that PCA protects against oxido-inflammatory pathways, enhanced caspases 3 and 9 activations induced by furan in rat hepatorenal system.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Necrose Tumoral alfa / Furanos / Hidroxibenzoatos / Rim / Fígado Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Necrose Tumoral alfa / Furanos / Hidroxibenzoatos / Rim / Fígado Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article